-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… to lower testosterone levels. Of men who have undergone definitive prostate cancer treatment, including … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study
24 Apr 2024 23:09 GMT
ADT in PC patients leads to an increase in fat mass and to a decrease in lean mass, thus increasing the risk of sarcopenic obesity. In addition, ADT has also a negative impact on skeletal fragility, which increases the risk of fractures. During the recent …
-
Masturbating might slash risk of prostate cancer, claims expert (and more is better!)
24 Apr 2024 12:48 GMT
… may help protect against prostate cancer.
Dr Kelly wrote: … ejaculation can reduce prostate cancer by decreasing the … low testosterone levels have a heightened risk of prostate cancer and … quickly does it develop?
Prostate cancer usually develops slowly, so …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… to lower testosterone levels.4 Of men who have undergone definitive prostate cancer treatment … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Does ejaculating often reduce your risk of prostate cancer?
23 Apr 2024 16:27 GMT
… prostate cancer risk. Specifically, does ejaculation protect against prostate cancer … ejaculation frequency on prostate cancer risk.
Although … the detection of prostate tumours with highly … that high testosterone levels in men raise prostate cancer risk, …
-
Orgovyx Manages Testosterone, Reduces Side Effects in Prostate Cancer
16 Apr 2024 01:15 GMT
… 260 patients with prostate cancer receiving radiotherapy and … patients receiving radiotherapy for prostate cancer.”
The injectable treatments, … recover to normal testosterone levels within two years … recovered to normal testosterone levels within 90 days …
-
Castration ‘An Unfortunate Term’ for Key Part of Prostate Cancer Treatment
12 Apr 2024 20:49 GMT
… treating patients with prostate cancer, controlling testosterone levels in the body … we used for prostate cancer previously, where you … way to treat advanced prostate cancers,” Choudhury said. “Here … achieve erections while their testosterone levels are low.
“ …
-
Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
09 Apr 2024 10:35 GMT
… cancer control in unfavorable localized prostate cancer treated with radiotherapy. ADT is … higher scores reflecting less bother. Testosterone levels were measured at each follow … reducing patient anxiety. Measuring testosterone levels at follow-up visits may …
-
Relugolix Rapidly Achieves Sustained Castration in Prostate Cancer Patients Undergoing Radiotherapy: Study
03 Apr 2024 23:56 GMT
… castration in prostate cancer patients undergoing radiotherapy … patients achieved testosterone levels comparable to baseline … treatment option for prostate cancer patients, offering … improving outcomes for prostate cancer patients undergoing radiotherapy …
-
PotentStream Reviewed – What Does the Science Say About Ingredients? (Benefits, Side Effects)
25 Apr 2024 01:15 GMT
… the diagnosis of prostate cancer and Benign Prostatic Hyperplasia … reduces the risk of prostate cancer, eases urinary discomfort, … prevents the growth of prostate cancer cells.
The Benefits … prostate glands, restores testosterone levels, and promotes sexual …